0 CHECKOUT

Gabon Pharmaceuticals and Healthcare Report Q2 2016

  • ID: 3621218
  • February 2016
  • Region: Gabon
  • 55 pages
  • Business Monitor International
1 of 3

Gabon's small pharmaceutical market size will continue to discourage investment from multinational pharmaceutical companies. Over the long-term, the country's evolving demographic profile, boosts to domestic manufacturing capabilities, and the success of the national health insurance scheme will provide momentum for pharmaceutical expenditure. However questions will be asked over the financial sustainability of the national health insurance scheme. Cost-containment measures are increasingly being encouraged by the Gabonese government, shifting the market in favour of generic medicines, thus supporting domestic pharmaceutical production. However, Gabon will continue to rely on pharmaceutical imports over the long-term.

Headline Expenditure Projections

- Pharmaceuticals: XAF48.14bn (USD81mn) in 2015 to XAF51.04bn (USD83mn) in 2016; +6.0% in local currency and +3.1% in US dollar terms. Forecast unchanged from Q116.

- Healthcare: XAF331.02bn (USD555mn) in 2015 to XAF358.69bn (USD585mn) in 2016; +8.4% in local currency and +5.4% in US dollar terms. Forecast unchanged from Q116.

Note: Product cover images may vary from those shown
2 of 3

- Industry View

- Table: Headline Pharmaceuticals & Healthcare Forecasts (Gabon 2014-2020)

- SWOT

- Industry Forecast

- Pharmaceutical Market Forecast

- Table: Pharmaceutical Sales, Historical Data And Forecasts (Gabon 2012-2020)

- Healthcare Market Forecast

- Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Gabon 2012-2020)

- Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Gabon 2012-2020)

- Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Gabon 2012-2020)

- Pharmaceutical Trade Forecast

- Table: Pharmaceutical Trade Data And Forecasts local currency (Gabon 2014-2020)

- Table: Pharmaceutical Trade Data And Forecasts (Gabon 2014-2020)

- Industry Risk Reward Index

- Middle East and Africa Risk/Reward Index - Q2 2016

- Gabon Risk/Reward Index

- Rewards

- Risks

- Regulatory Review

- Regulatory Environment

- Regulatory Regime

- Intellectual Property Issues

- Pricing Regime

- Reimbursement Regime

- Market Overview

- Healthcare Sector

- Research & Development

- Clinical Trials

- Epidemiology

- Competitive Landscape

- Research-Based Industry

- Table: Multinational Market Activity

- Generic Drugmakers

- Pharmaceutical Distribution

- Pharmaceutical Retail Sector

- Demographic Forecast

- Table: Population Headline Indicators (Gabon 1990-2025)

- Table: Key Population Ratios (Gabon 1990-2025)

- Table: Urban/Rural Population & Life Expectancy (Gabon 1990-2025)

- Table: Population By Age Group (Gabon 1990-2025)

- Table: Population By Age Group % (Gabon 1990-2025)

- Glossary

- Methodology

- Pharmaceutical Expenditure Forecast Model

- Healthcare Expenditure Forecast Model

- Notes On Methodology

- Risk/Reward Index Methodology

- Index Overview

- Table: Pharmaceutical Risk/Reward Index Indicators

- Indicator Weightings

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Db

Our Clients

  • Amneal Pharmaceuticals LLC.
  • Amgen Inc.
  • LEO Laboratories Ltd.
  • Pfizer Inc.
  • Roche Diagnostics Ltd.
  • Merck & Co., Inc.
  • Sanofi S.A.